Harvard Bioscience
HBIO
79 hedge funds and large institutions have $116M invested in Harvard Bioscience in 2015 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 10 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 22
6% more capital invested
Capital invested by funds: $109M → $116M (+$7.01M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1% less funds holding
Funds holding: 80 → 79 (-1)
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$3.96M |
| 2 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$3.76M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
+$1.45M |
| 4 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
+$1.39M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$805K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HSA
Hussman Strategic Advisors
Ellicott City,
Maryland
|
-$5.15M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.64M |
| 3 |
VDBMI
Van Den Berg Management I
Austin,
Texas
|
-$1.43M |
| 4 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$917K |
| 5 |
BG
BlackRock Group
London,
United Kingdom
|
-$510K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Federated Hermes
Pittsburgh,
Pennsylvania
| $2K | -$7.9K | -147 | -81% |
|
|
LTFS
77
Ladenburg Thalmann Financial Services
Miami,
Florida
| $2K | – | – | – |
|
78
Citigroup
New York
| $1K | -$107 | -2 | -8% |
|
|
HSA
79
Hussman Strategic Advisors
Ellicott City,
Maryland
| – | -$5.15M | -90,800 | Closed |
|
|
VDBMI
80
Van Den Berg Management I
Austin,
Texas
| – | -$1.43M | -25,229 | Closed |
|
|
CCP
81
Centaur Capital Partners
Southlake,
Texas
| – | -$284K | -5,000 | Closed |
|
|
RCM
82
Rotella Capital Management
Bellevue,
Washington
| – | -$119K | -2,095 | Closed |
|
83
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
| – | -$73K | -1,280 | Closed |
|
|
VKH
84
Virtu KCG Holdings
New York
| – | -$71K | -1,254 | Closed |
|
|
BGIM
85
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
| – | -$53K | -924 | Closed |
|
|
SGAM
86
Smith Group Asset Management
Dallas,
Texas
| – | -$29K | -510 | Closed |
|
|
TDC
87
Thompson Davis & Co
Richmond,
Virginia
| – | -$1K | -25 | Closed |
|
HBIO Hedge Fund Activity: Q1 2015 in Review
79 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Harvard Bioscience (HBIO) for Q1 2015, worth a combined $116M — up 6.4% from $109M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of HBIO and 9 opened new positions — a net loss of 1 holder — while 22 trimmed existing stakes and 28 added.
The largest buyer was Polar Asset Management Partners, opening a new position worth an estimated $3.96M. The largest seller was Hussman Strategic Advisors, exiting entirely with an estimated $5.15M sold.
- 79 institutional investors held Harvard Bioscience (HBIO) as of Q1 2015, down from 80 in Q4 2014.
- Funds reported $116M of Harvard Bioscience stock for Q1 2015, up 6.4% quarter-over-quarter.
- 9 funds opened new Harvard Bioscience positions in Q1 2015 and 10 closed out, a net change of -1 holder.
- The largest Harvard Bioscience buyer in Q1 2015 was Polar Asset Management Partners, an estimated $3.96M added.
- The largest Harvard Bioscience seller in Q1 2015 was Hussman Strategic Advisors, an estimated $5.15M sold.
Based on aggregated 13F filings for Q1 2015.